were transferred and diluted with same so as to give It is used in the treatment of type-2 diabetes mellitus 2 . It is several dilutions in concentration range of 50-250 µg/ml official in USP 3 which describes liquid chromatographic of repaglinide. To 5 ml of each dilution taken in a method for its quantitation. Literature survey reveals separating funnel, 5 ml of zincon HPLC 4-6 methods for the estimation of repaglinide from Reaction mixture was shaken plasma and pharmaceutical formulation. The objective of allowed to stand for 5 min so as to separate aqueous and the present investigation is to develop simple, accurate chloroform layer. The chloroform layer was separated out and economical spectrophotometric methods for the and absorbance maxima measured at 533.0 nm against a estimation of repaglinide in tablet formulation. reagent blank. Calibration curve was plotted between concentration of repaglinide and measured absorbance. Thermospectronic UV1, UV/Vis double beam spectrophotometer with spectral bandwidth of 2 nm, For method II, in a series of 10 ml volumetric flasks, wavelength accuracy of ±0.5 and 1 cm matched quartz aliquots of standard drug solution (1 mg/ml) in chloroform cells was used for analytical method development. All the were transferred and diluted with same so as to give several chemicals and reagents used were of analytical grade. Zincon dilutions in concentration range of 100-500 µg/ml of (2-[α-(2'-hydroxy-5'-sulfophenylazo)-bezylidine]hydrazino) repaglinide. To 5 ml of each dilution taken in a separating benzoic acid monosodium salt, (Thomas Baker, Mumbai) funnel, 5 ml of methylthymol blue reagent was added.
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studies.
reagent was added. gently for 5 min and reagent was prepared in acid phthalate buffer of pH 1.2 and methylthymol blue (CDH, New Delhi) reagent was prepared in acid phthalate buffer of pH 2.0. Both the reagents were prepared in double distilled water and extracted several times with chloroform so as to remove chloroform soluble impurities. Tablet formulation of repaglinide (Torrent, Ahemedabad) was procured from a local pharmacy. Standard solution of repaglinide was prepared by dissolving 100 mg in 100 ml of chloroform to give stock solution of concentration 1 mg/ml of drug.
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Reaction mixture was shaken gently for 5 min and allowed to stand for 5 min so as to separate aqueous and chloroform layer. The chloroform layer was separated out and absorbance measured at 427.0 nm against a reagent blank. Calibration curve was plotted between concentration of repaglinide and measured absorbance.
For analysis of tablet formulation, twenty tablets (1.0 mg and 2.0 mg) of repaglinide were weighed accurately and finely powdered. An accurately weighed portion of powdered sample, equivalent to 15 mg of repaglinide was taken in a 50 ml volumetric flask containing 25 ml of chloroform, sonicated for 20 minutes. www.ijpsonline.com The resultant was filtered through Whatman filter paper precision of the proposed methods. Statistical analysis was No. 41 into another 50 ml volumetric flask. The filter carried out and the results of which were satisfactory. diluted paper was washed several times with chloroform. The Standard deviation and relative standard deviation values washings were added to the filtrate and the final volume were low that indicated reproducibility of the proposed was made up to the mark with chloroform.
methods. It was observed that excipients did not interfere in the determination of repaglinide. Hence these For method I, 5 ml filtrate of the sample solution was developed methods could be used for routine estimation to 10 ml with chloroform and treated as per the of repaglinide in its tablet dosage forms. procedure of the calibration curve. Amount of the drug present in sample was computed from respective
